Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Report

China Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Market Research Report 2023-2029

  • POSTDATE：Sep 10, 2023
  • PAGES：174
  • REPORT CODE：GMM1786913
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • CAR T-cell therapy is a cancer treatment that uses a patient’s own immune system cells, called T cells, after these cells have been modified to better recognize and kill the patient’s cancer. The T cells are engineered in the laboratory and then expanded to large numbers and infused back into the patient. This type of treatment transfers an immune system into the patient that is capable of immediately killing the cancer. CAR stands for chimeric antigen receptor, which represents the genetically engineered portion of the T cell. The CAR part of the T cell contains proteins that allow the T cells to recognize the specific cancer cells as well as become highly activated to kill the cancer cells.

    This report elaborates on the current development of the Chimeric Antigen Receptor (CAR) T-Cell Therapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Editas Medicine Inc

    • Bellicum Phamaceuticals

    • Puretech Health

    • Servier Laboratories

    • Avacta Life Sciences Ltd

    • iCell Gene Therapeutics

    • Medimmune Llc/Astrazeneca

    • Kite Pharma Inc (A Subsidiary of Gilead Sciences Inc)

    • Noile-Immune Biotech

    • Takeda Pharmaceuticals

    • Protheragen Inc

    • Shire Pharmaceuticals Inc

    • Eureka Therapeutics Inc

    • Juno Therapeutics Inc (A Celgene Company)

    • Novartis AG

    • Amgen

    • Celyad SA

    • Transgene SA

    • Bluebird Bio

    • F Hoffman La Roche AG

    • Cellectis

    • Formula Pharmaceuticals Inc

    By Type:

    • Advanced Lymphomas

    • Others

    • Acute Lymphoblastic Leukemia (ALL)

    By Application:

    • Children

    • Adult

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview 2018-2029

    • 1.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development Overview

    • 1.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development History

    • 1.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Market Size (2018-2029)

    • 1.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Type from Production Side

      • 1.4.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume, Production Value and Growth Rate of Advanced Lymphomas (2018-2029)

      • 1.4.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume, Production Value and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2018-2029)

    • 1.5 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Application from Consumption End

      • 1.5.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Sales Value and Growth Rate of Children (2018-2029)

      • 1.5.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Sales Value and Growth Rate of Adult (2018-2029)

    • 1.6 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Region

      • 1.6.1 North China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

    Chapter 2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Competition Analysis in 2023

      • 2.2.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development

    Chapter 3 Chimeric Antigen Receptor (CAR) T-Cell TherapyIndustry Chain Analysis

    • 3.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Chain

    • 3.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market

    • 3.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market

    Chapter 4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Type

    • 4.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Total Production Volume and Growth Rate from Production Side

    • 4.5 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume and Growth Rate, by Type

      • 4.5.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume and Growth Rate of Advanced Lymphomas

      • 4.5.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume and Growth Rate of Others

      • 4.5.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume and Growth Rate of Acute Lymphoblastic Leukemia (ALL)

    Chapter 5 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Total Market Size and Growth Rate from Consumption End

    • 5.5 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate, by Application

      • 5.5.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate of Children

      • 5.5.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate of Adult

    Chapter 6 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Region

    • 6.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume and Production Value, by Region

    • 6.2 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Sales Value, by Region

    Chapter 7 North China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis

    • 7.1 North China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Type

    • 7.2 North China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Application

    Chapter 8 Central China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis

    • 8.1 Central China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Type

    • 8.2 Central China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Application

    Chapter 9 South China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis

    • 9.1 South China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Type

    • 9.2 South China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Application

    Chapter 10 East China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis

    • 10.1 East China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Type

    • 10.2 East China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Application

    Chapter 11 Northeast China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis

    • 11.1 Northeast China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Type

    • 11.2 Northeast China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Application

    Chapter 12 Southwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis

    • 12.1 Southwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Type

    • 12.2 Southwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Application

    Chapter 13 Northwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis

    • 13.1 Northwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Type

    • 13.2 Northwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Editas Medicine Inc

        • 14.1.1 Editas Medicine Inc Company Profile

        • 14.1.2 Editas Medicine Inc Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bellicum Phamaceuticals

        • 14.2.1 Bellicum Phamaceuticals Company Profile

        • 14.2.2 Bellicum Phamaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Puretech Health

        • 14.3.1 Puretech Health Company Profile

        • 14.3.2 Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Servier Laboratories

        • 14.4.1 Servier Laboratories Company Profile

        • 14.4.2 Servier Laboratories Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Avacta Life Sciences Ltd

        • 14.5.1 Avacta Life Sciences Ltd Company Profile

        • 14.5.2 Avacta Life Sciences Ltd Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 iCell Gene Therapeutics

        • 14.6.1 iCell Gene Therapeutics Company Profile

        • 14.6.2 iCell Gene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Medimmune Llc/Astrazeneca

        • 14.7.1 Medimmune Llc/Astrazeneca Company Profile

        • 14.7.2 Medimmune Llc/Astrazeneca Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Kite Pharma Inc (A Subsidiary of Gilead Sciences Inc)

        • 14.8.1 Kite Pharma Inc (A Subsidiary of Gilead Sciences Inc) Company Profile

        • 14.8.2 Kite Pharma Inc (A Subsidiary of Gilead Sciences Inc) Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Noile-Immune Biotech

        • 14.9.1 Noile-Immune Biotech Company Profile

        • 14.9.2 Noile-Immune Biotech Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Takeda Pharmaceuticals

        • 14.10.1 Takeda Pharmaceuticals Company Profile

        • 14.10.2 Takeda Pharmaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Protheragen Inc

        • 14.11.1 Protheragen Inc Company Profile

        • 14.11.2 Protheragen Inc Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Shire Pharmaceuticals Inc

        • 14.12.1 Shire Pharmaceuticals Inc Company Profile

        • 14.12.2 Shire Pharmaceuticals Inc Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Eureka Therapeutics Inc

        • 14.13.1 Eureka Therapeutics Inc Company Profile

        • 14.13.2 Eureka Therapeutics Inc Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Juno Therapeutics Inc (A Celgene Company)

        • 14.14.1 Juno Therapeutics Inc (A Celgene Company) Company Profile

        • 14.14.2 Juno Therapeutics Inc (A Celgene Company) Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Novartis AG

        • 14.15.1 Novartis AG Company Profile

        • 14.15.2 Novartis AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Amgen

        • 14.16.1 Amgen Company Profile

        • 14.16.2 Amgen Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Celyad SA

        • 14.17.1 Celyad SA Company Profile

        • 14.17.2 Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Transgene SA

        • 14.18.1 Transgene SA Company Profile

        • 14.18.2 Transgene SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Bluebird Bio

        • 14.19.1 Bluebird Bio Company Profile

        • 14.19.2 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 F Hoffman La Roche AG

        • 14.20.1 F Hoffman La Roche AG Company Profile

        • 14.20.2 F Hoffman La Roche AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 Cellectis

        • 14.21.1 Cellectis Company Profile

        • 14.21.2 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Formula Pharmaceuticals Inc

        • 14.22.1 Formula Pharmaceuticals Inc Company Profile

        • 14.22.2 Formula Pharmaceuticals Inc Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Performance

        • 14.22.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Research Conclusions

    • 15.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Market Size (2018-2029)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume, Production Value and Growth Rate of Advanced Lymphomas (2018-2029)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume, Production Value and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2018-2029)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Sales Value and Growth Rate of Children (2018-2029)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Sales Value and Growth Rate of Adult (2018-2029)

    • Figure North China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure Central China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure South China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure East China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type in 2018

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Type in 2023

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume and Growth Rate of Advanced Lymphomas (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application in 2018

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share by Application in 2023

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Total Market Size and Growth Rate from Consumption End

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate of Children (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate of Adult (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Region (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value Share by Region (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Value Share by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Region (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Value by Region (2018-2023)

    • Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Value Share by Region (2018-2023)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Value Share by Region (2018-2023)

    • Table North China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume by Type (2018-2023)

    • Table North China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure North China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Table North China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Application (2018-2023)

    • Table North China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure North China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table Central China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume by Type (2018-2023)

    • Table Central China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure Central China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Table Central China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Application (2018-2023)

    • Table Central China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure Central China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table South China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume by Type (2018-2023)

    • Table South China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure South China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Table South China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Application (2018-2023)

    • Table South China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure South China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table East China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume by Type (2018-2023)

    • Table East China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure East China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Table East China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Application (2018-2023)

    • Table East China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure East China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table Northeast China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume by Type (2018-2023)

    • Table Northeast China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure Northeast China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Table Northeast China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Application (2018-2023)

    • Table Northeast China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table Southwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume by Type (2018-2023)

    • Table Southwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure Southwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Table Southwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Application (2018-2023)

    • Table Southwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table Northwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume by Type (2018-2023)

    • Table Northwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure Northwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Production Volume Share by Type (2018-2023)

    • Table Northwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Application (2018-2023)

    • Table Northwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table Editas Medicine Inc Company Profile

    • Table Editas Medicine Inc Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Bellicum Phamaceuticals Company Profile

    • Table Bellicum Phamaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Puretech Health Company Profile

    • Table Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Servier Laboratories Company Profile

    • Table Servier Laboratories Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Avacta Life Sciences Ltd Company Profile

    • Table Avacta Life Sciences Ltd Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table iCell Gene Therapeutics Company Profile

    • Table iCell Gene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Medimmune Llc/Astrazeneca Company Profile

    • Table Medimmune Llc/Astrazeneca Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Kite Pharma Inc (A Subsidiary of Gilead Sciences Inc) Company Profile

    • Table Kite Pharma Inc (A Subsidiary of Gilead Sciences Inc) Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Noile-Immune Biotech Company Profile

    • Table Noile-Immune Biotech Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceuticals Company Profile

    • Table Takeda Pharmaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Protheragen Inc Company Profile

    • Table Protheragen Inc Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Shire Pharmaceuticals Inc Company Profile

    • Table Shire Pharmaceuticals Inc Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Eureka Therapeutics Inc Company Profile

    • Table Eureka Therapeutics Inc Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Juno Therapeutics Inc (A Celgene Company) Company Profile

    • Table Juno Therapeutics Inc (A Celgene Company) Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Celyad SA Company Profile

    • Table Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Transgene SA Company Profile

    • Table Transgene SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Bluebird Bio Company Profile

    • Table Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table F Hoffman La Roche AG Company Profile

    • Table F Hoffman La Roche AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Cellectis Company Profile

    • Table Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Formula Pharmaceuticals Inc Company Profile

    • Table Formula Pharmaceuticals Inc Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US